Navigation Links
Prometheus Announces New Chief Medical Officer
Date:11/14/2011

SAN DIEGO, Nov. 14, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the appointment of Dr. Peter Heseltine as Senior Vice President and Chief Medical Officer.

Dr. Heseltine joins Prometheus with almost 35 years of experience in the medical field.  He comes most recently from Beckman Coulter where he served as Vice President and Medical Director of Global Businesses since 2005. In this role he had corporate responsibility for medical input and oversight of in vitro diagnostics product design, development and life cycle management, including new cancer diagnostics, using immunoassay, flow cytometry and molecular technologies.

Prior to joining Beckman Coulter, Dr. Heseltine was Medical Director of Infectious Diseases at Nichols Institute Quest Diagnostics supervising high-volume, Molecular, Microbiology, Virology and Serology clinical laboratories. He formed a team of research scientists to develop new esoteric tests for infectious diseases under ISO 9001 standards and led a Six Sigma quality improvement program that introduced more than 50 new tests in four years.  Prior to joining Quest Diagnostics, Dr. Heseltine was a Chief Physician at Los Angeles County USC Hospital  and Professor of Medicine at the University of Southern California.  Dr. Heseltine received his medical training at Trinity College, Dublin University and postgraduate training at Yale University, the University of California, Los Angeles and the U. S. Centers for Disease Control. He is Board certified in Internal Medicine and Infectious Diseases. Dr. Heseltine is a Fellow of the American College of Physicians, Fellow of the National Academy of Clinical Biochemistry and a Fellow of the Infectious Diseases Society of America. He maintains a position as Clinical Professor of Medicine at the University of California, Irvine.

"Peter brings a wealth of medical, clinical and product development experience which will be very valuable during this important stage of our company's growth," said Joseph M. Limber, President and Chief Executive Officer of Prometheus. "He is a welcome addition to our senior management team and will play a key role in planning and executing our core strategy as we continue to build on our success."

About Prometheus

Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary diagnostic testing services. By integrating therapeutics and diagnostics, Prometheus believes it can provide physicians with more targeted solutions to optimize care for their patients. Prometheus became part of Nestle Health Science in July 2011.  Prometheus' corporate offices are located in San Diego, California. For more information about Prometheus, please visit www.prometheuslabs.com.

About Nestle Health Science

Nestle Health Science, a fully-owned subsidiary of Nestle S.A., is operational since January 1, 2011 and has worldwide headquarters in Lutry, Switzerland. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. For more information about Nestle Health Science, please visit www.nestlehealthscience.com.


'/>"/>
SOURCE Prometheus Laboratories Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
2. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
3. Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
4. Prometheus Launches ProOnc Dx Cancer Diagnostics
5. Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
6. Prometheus Announces New Method for Real-Time Monitoring of Patients Treated With Biologic Therapy
7. Prometheus and Bayer HealthCare Enter into Services Agreement to Conduct Mutational Analysis
8. Prometheus Highlights Record Performance in 2010
9. Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX®
10. Prometheus Announces Agreement to be Acquired by Nestle Health Science
11. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
(Date:6/7/2017)... DUBLIN , June 7, 2017 Endo ... on June 7, 2017, the Hon. Joseph R. ... District of West Virginia , entered ... Systems, Inc. Pelvic Repair System Products Liability Litigation (the ... filed MDL cases to provide expert disclosures on specific ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... 22, 2017 , ... United Benefit Advisors (UBA), the nation’s ... as its newest Partner Firm. Headquartered in Coconut Creek, Florida, Whipple & Company ... optimized benefit packages that strengthen the relationship between employer and employee. , “We ...
(Date:6/22/2017)... ... June 23, 2017 , ... Despite its pervasiveness, many ... reviews available that integrate basic science with clinical practice. Now, however, a timely review ... providing clinicians with insight into the etiology of NeuP and educating preclinical scientists on ...
(Date:6/22/2017)... ... 22, 2017 , ... A June 12 article in The Star ... apparent lack of oral hygiene by an aged parent who had recently suffered a ... a number of steps, including scheduling a dentist visit. Northridge Dental Works, a Los ...
(Date:6/20/2017)... ... June 20, 2017 , ... Connance, a ... system, will present how predictive analytics drive reimbursement optimization, with a focus on ... June 25-28. , “The traditional approach to denied and underpaid claims leaves ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
Breaking Medicine News(10 mins):